Decreased levels of circulating trimethylamine N-oxide alleviate cognitive and pathological deterioration in transgenic mice: a potential therapeutic approach for Alzheimer’s disease

Trimethylamine-N-oxide (TMAO), a metabolite of gut microbiota, has been implicated in the pathogenesis of Alzheimer’s disease (AD). However, the mechanisms by which TMAO influence cognitive and pathological processes in the AD have not been investigated. In this study, we found that the circulating...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Qiang, Wang, Yuan, Wang, Xin, Fu, Shuang, Zhang, Xin, Wang, Rui-Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6814608/
https://www.ncbi.nlm.nih.gov/pubmed/31612864
http://dx.doi.org/10.18632/aging.102352

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6814608/
https://www.ncbi.nlm.nih.gov/pubmed/31612864
http://dx.doi.org/10.18632/aging.102352

Ejemplares similares